Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

Pacemakers can detect AF and enable initiation of anticoagulation for stroke prevention

Pacemakers can detect asymptomatic AF but are not routinely monitored for this purpose. The current study investigated whether pacemaker checks could be used to identify patients with asymptomatic AF who could then be given anticoagulation for stroke prevention.

19 Oct 2015

Genetic mutation linked to ALS, FTD prevents proteins from entering and exiting the cell's nucleus

Three teams of scientists supported by the National Institutes of Health showed that a genetic mutation linked to some forms of amyotrophic lateral sclerosis (ALS) and frontotemporal degeneration (FTD) may destroy neurons by disrupting the movement of materials in and out of the cell's nucleus, or command center where most of its DNA is stored.

19 Oct 2015

FDA grants accelerated approval to Praxbind (idarucizumab)

The U.S. Food and Drug Administration today granted accelerated approval to Praxbind (idarucizumab) for use in patients who are taking the anticoagulant Pradaxa (dabigatran) during emergency situations when there is a need to reverse Pradaxa's blood-thinning effects.

19 Oct 2015

Primary care physicians often under- or over-estimate stroke and bleeding risk in AF patients

Patients with atrial fibrillation (AF) have an increased risk for stroke and are often prescribed oral anticoagulation (OAC) therapy. OAC therapy can prevent disastrous strokes, but at the expense of increased bleeding risks. There are now well-established guidelines to assess the risk of stroke and bleeding in AF patients to determine whether OAC is needed.

19 Oct 2015

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

Boehringer Ingelheim Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration granted approval of Praxbind (idarucizumab). PRAXBIND is indicated for patients treated with Pradaxa (dabigatran etexilate mesylate), when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding.

16 Oct 2015

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Researchers in the Adult Genetic Epilepsy Program of the Krembil Neuroscience Centre have discovered a gene mutation that increases the risk of sudden unexpected death in epilepsy (SUDEP) in patients with mild forms of the disease.

16 Oct 2015

Synapse Biomedical, IFR to commercialize implantable systems that restore muscle function in paralyzed patients

Case Western Reserve University's Institute for Functional Restoration (IFR) and Synapse Biomedical Inc. have entered a partnership to commercialize fully implantable systems that restore muscle function in paralyzed patients.

16 Oct 2015

OHSU designs new iPhone app to advance melanoma research

Oregon Health & Science University today released an iPhone app designed to advance melanoma research by giving users the ability to accurately measure and monitor moles, and contribute photos of how their potential trouble spots evolve over time.

16 Oct 2015

Big data and analytics expected to play major role in Singapore’s healthcare market

Continuous data collection for chronic illness management is crucial to deliver personalized care for patients. In the era of globalization, patients still do not have the right tools to collect and share their physiological information on a frequent, real time basis.

16 Oct 2015

New method uses advanced noninvasive neuroimaging to localize and identify epileptic lesions

Epilepsy affects more than 65 million people worldwide. One-third of these patients have seizures that are not controlled by medications. In addition, one-third have brain lesions, the hallmark of the disease, which cannot be located by conventional imaging methods.

15 Oct 2015

Developing tailored interventions for cognitive and behavioral symptoms key to improving outcomes after TBI

Kessler researchers assessed moderate to severe traumatic brain injury (TBI) for frontal behavioral syndromes and cognitive function. Their finding suggest that adding the Frontal Systems Behavior Scale to neuropsychological assessment may yield useful information about the behavioral sequelae of TBI.

15 Oct 2015

Poorly-designed animal study threatens validity of preclinical research

Badly designed studies may lead to the efficacy of drugs being overestimated and money being wasted on trials that prove fruitless, according to new a study from McGill University in Canada.

15 Oct 2015

UTHealth biochemists expose structures of IP3R calcium channels

Calcium is a crucial element in the body that controls thought, movement and other bodily functions. These events are directed by specialized proteins called ion channels that allow the flow of calcium ions in and out of cells and among cell compartments. For years, scientists have been unsure how calcium ion channels function.

15 Oct 2015

Having a high stress job may increase risk of stroke

Having a high stress job may be linked to a higher risk of stroke, according to an analysis of several studies. The meta-analysis is published in the October 14, 2015, online issue of Neurology, the medical journal of the American Academy of Neurology.

15 Oct 2015

SRS microscope technology gives surgeons real-time microscopic vision of brain tumors

Brain tumor tissue can be hard to distinguish from normal brain during surgery. Neurosurgeons use their best judgment in the operating room but often must guess exactly where the edges of the tumor are while removing it.

15 Oct 2015

The Medical Center of Plano Partners with BIND, Brain Injury Network of Dallas to support survivors of traumatic brain injuries

Supporting patients who have suffered a serious brain injury is the goal of a new partnership between The Medical Center of Plano and the Brain Injury Network of Dallas, also called BIND.

15 Oct 2015

Antipsychotic drugs more frequently used in Alzheimer's disease patients, new study finds

Antipsychotic drugs are initiated in patients with Alzheimer's disease (AD) more frequently than in the general population - already 2-3 years before the Alzheimer's diagnosis, according to a new study from the University of Eastern Finland.

14 Oct 2015

Antipsychotics initiated frequently and used for long term in Alzheimer's patients

Antipsychotic drugs are initiated in patients with Alzheimer's disease (AD) more frequently than in the general population – already 2–3 years before the Alzheimer's diagnosis, according to a new study from the University of Eastern Finland. Most commonly, antipsychotics were initiated during the six months following the Alzheimer's diagnosis; however, the incidence of new antipsychotic users was high also later on. The results were published in British Journal of Psychiatry.

14 Oct 2015

Lowering systolic blood pressure can reduce risk of left ventricular hypertrophy

Lowering systolic blood pressure below the currently recommended target can reduce the risk of left ventricular hypertrophy (LVH), the most common complication of high blood pressure, according to new research.

14 Oct 2015

Sitting for long periods does not increase early death risk, researchers say

New research from the University of Exeter and University College London has challenged claims that sitting for long periods increases the risk of an early death even if you are otherwise physically active.

14 Oct 2015

Stroke News and Research

Further Reading

Pacemakers can detect AF and enable initiation of anticoagulation for stroke prevention

Genetic mutation linked to ALS, FTD prevents proteins from entering and exiting the cell's nucleus

FDA grants accelerated approval to Praxbind (idarucizumab)

Primary care physicians often under- or over-estimate stroke and bleeding risk in AF patients

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

Study reveals gene mutation that increases risk of SUDEP in patients with mild forms of disease

Synapse Biomedical, IFR to commercialize implantable systems that restore muscle function in paralyzed patients

OHSU designs new iPhone app to advance melanoma research

Big data and analytics expected to play major role in Singapore’s healthcare market

New method uses advanced noninvasive neuroimaging to localize and identify epileptic lesions

Developing tailored interventions for cognitive and behavioral symptoms key to improving outcomes after TBI

Poorly-designed animal study threatens validity of preclinical research

UTHealth biochemists expose structures of IP3R calcium channels

Having a high stress job may increase risk of stroke

SRS microscope technology gives surgeons real-time microscopic vision of brain tumors

The Medical Center of Plano Partners with BIND, Brain Injury Network of Dallas to support survivors of traumatic brain injuries

Antipsychotic drugs more frequently used in Alzheimer's disease patients, new study finds

Antipsychotics initiated frequently and used for long term in Alzheimer's patients

Lowering systolic blood pressure can reduce risk of left ventricular hypertrophy

Sitting for long periods does not increase early death risk, researchers say

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News